微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 3.59% | -32.26% | 136.18% | 42/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 1.52% | -41.09% | -80.66% | 56/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 7.86% | -54.54% | 0.26% | 32/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 7.84% | -42.73% | 47.92% | 24/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 5.3% | -39.29% | 105.43% | 23/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 2.58% | -55.44% | -85.08% | 29/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 17.29% | -11.24% | 26.3% | 6/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 13.69% | 3.79% | 56.82% | 7/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 8.73% | 6.59% | 50.78% | 8/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 5.79% | -0.17% | -70.28% | 5/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 19.48% | 12.02% | 47.69% | 5/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 13.19% | 12.26% | 61.05% | 8/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 8.19% | 13.43% | 41.21% | 15/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 5.8% | 11.54% | -66.65% | 9/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 17.39% | 26.2% | 48% | 35/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 11.75% | 11.69% | 62.74% | 47/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 7.22% | 21.14% | 38.85% | 51/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 5.2% | 12.8% | -62.26% | 31/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 13.78% | 21.95% | 30.99% | 64/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 10.52% | 20.92% | 76.51% | 58/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 5.96% | 9.36% | 29.28% | 72/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 4.61% | 30.59% | -59.2% | 34/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 11.3% | -3.17% | 29.89% | 83/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 8.7% | 13.13% | 59.63% | 58/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 5.45% | -12.52% | 54.39% | 69/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 3.53% | 2% | -69.75% | 22/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 11.67% | 42.32% | 51.76% | 69/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 7.69% | 101.84% | 23.43% | 41/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 6.23% | 2% | -24.02% | 31/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2018-12-31 | 8.2% | -10.68% | 115.22% | 78/141 | 14.23% | 新华医疗 | 13.55% | 行业排名> |
| 2018-09-30 | 3.81% | 2% | -58.5% | 48/141 | 9.71% | 安旭生物 | 48.71% | 行业排名> |
| 2017-12-31 | 9.18% | 2% | 2% | 68/141 | 14.51% | 迈瑞医疗 | 38.33% | 行业排名> |